Articles from Biotech Business (October 1, 2004)

Title	Author	Type	Words
ASCEND FILES PATENT FOR BENIGN BREAST DISEASE DRUG.			456
BCX-1777 GETS ORPHAN DRUG DESIGNATION FOR 2 MORE INDICATIONS.			442
BIOMARIN GETS POSITIVE DATA FROM VIBRILASE PHASE 1B TRIAL.			645
PHARMION SELECTS MCKESSON TO DISTRIBUTE VIDAZA.			417
PROVECTUS FILES FDA IND FOR TREATMENT OF MALIGNANT TUMORS.			363
VERTA AWARDED GOVERNMENT GRANT TO EVALUATE SCV-07.			475